Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis

Chaoyang Wang , Jinghong Yao , Huanzhang Niu , Chongtu Yang , Jiacheng Liu , Yaowei Bai , Shuguang Ju , Bin Xiong
{"title":"Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis","authors":"Chaoyang Wang ,&nbsp;Jinghong Yao ,&nbsp;Huanzhang Niu ,&nbsp;Chongtu Yang ,&nbsp;Jiacheng Liu ,&nbsp;Yaowei Bai ,&nbsp;Shuguang Ju ,&nbsp;Bin Xiong","doi":"10.1016/j.jimed.2022.09.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To evaluate the dynamic changes in liver function after transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with cirrhosis and to explore its association with clinical outcomes.</p></div><div><h3>Methods</h3><p>This retrospective study included patients who underwent TIPS between August 2016 and December 2020. Liver function was primarily evaluated using the model for end-stage liver disease (MELD) score, which was analyzed at baseline, 1 week, 1 month, 3 months, 6 months, and 12 months using one-way repeated measures ANOVA. The Kaplan-Meier method, log-rank test, and multivariate analysis were used as appropriate.</p></div><div><h3>Results</h3><p>In total, 235 patients were included in this study. The MELD score was significantly higher at 1 week (11.8 ​± ​3.1 vs 13.5 ​± ​3.5, p ​&lt; ​0.05) and 1 month (11.8 ​± ​3.1 vs 13.2 ​± ​4.6, p ​&lt; ​0.05) than the baseline level and recovered at 3 months (11.8 ​± ​3.1 vs 11.9 ​± ​3.9, p ​&gt; ​0.05). At 12 months, the MELD score was higher than the baseline level (11.8 ​± ​3.1 vs 12.4 ​± ​3.2, p ​&lt; ​0.05). Patients with a recovery of the MELD score (n ​= ​151) at 3 months had a lower probability of overt and severe HE (log-rank p ​= ​0.015 and p ​= ​0.027, respectively) than those without recovery (n ​= ​84). Logistic regression analysis revealed that albumin (odds ratio [OR], 0.926; 95% confidence interval [CI], 0.863–0.992; p ​= ​0.029) and platelet count (OR, 0.993; 95% CI, 0.987–0.999; p ​= ​0.033) were independent predictive factors for non-recovery of the MELD score at 3 months.</p></div><div><h3>Conclusions</h3><p>Liver function after TIPS creation showed a trend of deterioration at first, followed by recovery. Recovery of liver function at three months was associated with reduced overt and severe HE.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/c9/main.PMC9751219.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Interventional Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2096360222000515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To evaluate the dynamic changes in liver function after transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with cirrhosis and to explore its association with clinical outcomes.

Methods

This retrospective study included patients who underwent TIPS between August 2016 and December 2020. Liver function was primarily evaluated using the model for end-stage liver disease (MELD) score, which was analyzed at baseline, 1 week, 1 month, 3 months, 6 months, and 12 months using one-way repeated measures ANOVA. The Kaplan-Meier method, log-rank test, and multivariate analysis were used as appropriate.

Results

In total, 235 patients were included in this study. The MELD score was significantly higher at 1 week (11.8 ​± ​3.1 vs 13.5 ​± ​3.5, p ​< ​0.05) and 1 month (11.8 ​± ​3.1 vs 13.2 ​± ​4.6, p ​< ​0.05) than the baseline level and recovered at 3 months (11.8 ​± ​3.1 vs 11.9 ​± ​3.9, p ​> ​0.05). At 12 months, the MELD score was higher than the baseline level (11.8 ​± ​3.1 vs 12.4 ​± ​3.2, p ​< ​0.05). Patients with a recovery of the MELD score (n ​= ​151) at 3 months had a lower probability of overt and severe HE (log-rank p ​= ​0.015 and p ​= ​0.027, respectively) than those without recovery (n ​= ​84). Logistic regression analysis revealed that albumin (odds ratio [OR], 0.926; 95% confidence interval [CI], 0.863–0.992; p ​= ​0.029) and platelet count (OR, 0.993; 95% CI, 0.987–0.999; p ​= ​0.033) were independent predictive factors for non-recovery of the MELD score at 3 months.

Conclusions

Liver function after TIPS creation showed a trend of deterioration at first, followed by recovery. Recovery of liver function at three months was associated with reduced overt and severe HE.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝硬化患者经颈静脉肝内门体分流术后肝功能的动态变化
目的评价肝硬化患者经颈静脉肝内门体分流术(TIPS)后肝功能的动态变化,并探讨其与临床预后的关系。方法本回顾性研究纳入了2016年8月至2020年12月期间接受TIPS治疗的患者。使用终末期肝病(MELD)评分模型主要评估肝功能,并在基线、1周、1个月、3个月、6个月和12个月使用单向重复测量方差分析进行分析。酌情采用Kaplan-Meier法、log-rank检验和多变量分析。结果本研究共纳入235例患者。MELD评分在1周时显著升高(11.8±3.1 vs 13.5±3.5,p <0.05)和1个月(11.8±3.1 vs 13.2±4.6,p & lt;0.05), 3个月恢复(11.8±3.1 vs 11.9±3.9,p >0.05)。12个月时,MELD评分高于基线水平(11.8±3.1 vs 12.4±3.2,p <0.05)。3个月MELD评分恢复的患者(n = 151)发生明显和严重HE的概率(log-rank分别为p = 0.015和p = 0.027)低于未恢复的患者(n = 84)。Logistic回归分析显示,白蛋白(比值比[OR], 0.926;95%置信区间[CI], 0.863-0.992;p = 0.029)和血小板计数(OR, 0.993;95% ci, 0.987-0.999;p = 0.033)是3个月MELD评分未恢复的独立预测因素。结论TIPS术后银功能呈先恶化后恢复的趋势。3个月时肝功能恢复与明显和严重HE减少相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Interventional Medicine
Journal of Interventional Medicine Medicine-General Medicine
CiteScore
1.30
自引率
0.00%
发文量
32
审稿时长
68 days
期刊最新文献
Baseline parameters of spectral CT could predict tumor response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients Validation of the CRAFITY score for predicting prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization combined with systemic therapy Diagnostic radiology: The essential for effective and safe practice of interventional radiology Percutaneous radiofrequency and microwave ablation for renal pelvic urothelial carcinoma with refractory hematuria: A case report Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1